ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.869,36
0,78%
S&P 500
5.303,46
1,08%
Dow Jones
39.868,00
0,78%
Euro vs US Dollar
1,08807
0,61%
Bitcoin
66.092,35
7,38%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sophia Genetics SA (SOPH)

  7. Sophia Genetics SA (SOPH) News

SOPH

Sophia Genetics (SOPH)

Sophia Genetics SA
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SOPH
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202417h46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
13/05/202422h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
07/05/202413h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
07/05/202412h45GlobeNewswire Inc.SOPHiA GENETICS Reports First Quarter 2024 ResultsNASDAQ:SOPHSophia Genetics SA
30/04/202413h05GlobeNewswire Inc.SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
23/04/202416h29GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024NASDAQ:SOPHSophia Genetics SA
23/04/202411h05PR Newswire (US)SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in AfricaNASDAQ:SOPHSophia Genetics SA
17/04/202412h05PR Newswire (US)SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)NASDAQ:SOPHSophia Genetics SA
04/04/202407h00PR Newswire (US)SOPHiA GENETICS and Strand Life Sciences Announce New Strategic PartnershipNASDAQ:SOPHSophia Genetics SA
04/04/202407h00PR Newswire (US)SOPHiA GENETICS and Strand Life Sciences Announce New Strategic PartnershipNASDAQ:SOPHSophia Genetics SA
02/04/202416h00PR Newswire (US)Laboratorio Barnafi-Krause is Live on SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
20/03/202415h00PR Newswire (US)SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in CanadaNASDAQ:SOPHSophia Genetics SA
15/03/202411h00PR Newswire (US)SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear CollaborationNASDAQ:SOPHSophia Genetics SA
07/03/202418h07GlobeNewswire Inc.SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
05/03/202413h02Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SOPHSophia Genetics SA
05/03/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
05/03/202412h45GlobeNewswire Inc.SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:SOPHSophia Genetics SA
22/02/202414h45GlobeNewswire Inc.SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:SOPHSophia Genetics SA
20/02/202416h46GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024NASDAQ:SOPHSophia Genetics SA
07/02/202413h31PR Newswire (US)SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in SpainNASDAQ:SOPHSophia Genetics SA
07/02/202412h51PR Newswire (US)SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in SpainNASDAQ:SOPHSophia Genetics SA
25/01/202416h50PR Newswire (US)SOPHiA GENETICS Supports Genetic Testing in BrazilNASDAQ:SOPHSophia Genetics SA
18/01/202421h00PR Newswire (US)SOPHiA GENETICS Enhances RareCyte Precision Biology Services PortfolioNASDAQ:SOPHSophia Genetics SA
15/01/202405h00PR Newswire (US)SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in IndiaNASDAQ:SOPHSophia Genetics SA
15/01/202405h00PR Newswire (US)SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in IndiaNASDAQ:SOPHSophia Genetics SA
10/01/202423h15PR Newswire (US)SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
10/01/202422h59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
08/01/202415h08PR Newswire (US)Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data AnalyticsNASDAQ:SOPHSophia Genetics SA
21/12/202313h00PR Newswire (US)Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid DisordersNASDAQ:SOPHSophia Genetics SA
14/12/202318h43GlobeNewswire Inc.SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
 Showing the most relevant articles for your search:NASDAQ:SOPH

Kürzlich von Ihnen besucht

NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
NKE
Nike
DBI
DAX
DAX
NYSE
XOM
Exxon Mobil
TG
BAYN
Bayer
USOTC
ADDYY
Adidas (QX)
TG
432
Arbor Metals
CCOM
US30
US 30
TG
LHA
Deutsche Lufthansa
COIN
ETHUSD
Ethereum
USOTC
RHHBY
Roche (QX)
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten